The Study
Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activity
This study was done in a test tube, not in people or animals. It shows that two fungal substances might block a key enzyme involved in making cholesterol, but we don’t know if this would work in a living body.
Analysis score
Maximum 44 for a cross-sectional study.
Where the score came from
Scientists found that two substances made by fungi block a key step in making cholesterol by sticking to the enzyme that builds it.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 53 / 100
Quality score
Detailed descriptions of individual patients or small groups. Valuable for identifying new conditions or side effects, but cannot establish generalizable conclusions.
Key takeaways
Summary
Based on the study abstract and findings.
- 1This helps explain how these fungal substances might lower cholesterol in medicine.
- 2These substances only block the cholesterol-making enzyme and not others, and they work by competing with the enzyme's usual building block.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.